Evidence map›Paper›PMID 34099889›Full record

ArticleCellular & molecular immunology2021

Continuous activation of polymorphonuclear myeloid-derived suppressor cells during pregnancy is critical for fetal development.

Mengyu Shi, Ziyang Chen, Meiqi Chen, Jingping Liu, Jing Li, Zhe Xing, Xiaogang Zhang, Shuaijun Lv, Xinyao Li, Shaowen Zuo and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in Cellular & molecular immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Metabolic Reprogramming Driven by Trophoblasts and Decidual XCR1Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Defining myeloid-derived suppressor cells.Nature reviews. Immunology · 2024
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Mengyu Shi *Department of Immunology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China.
Ziyang Chen *Department of Immunology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China.
Meiqi Chen *Department of Immunology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China.
Jingping Liu *Department of Laboratory Medicine, the Third Affiliated Hospital of Southern Medical University, Southern Medical University, Guangzhou, China.
Jing LiDepartment of Obstetrics and Gynecology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Zhe XingDepartment of Immunology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China.
Xiaogang ZhangDepartment of Immunology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China.
Shuaijun LvDepartment of Immunology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China.
Xinyao LiDepartment of Immunology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China.
Shaowen ZuoDepartment of Immunology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China.
Shi FengDepartment of Immunology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China.
Ying LinDepartment of Immunology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China.
Gang XiaoDepartment of Laboratory Medicine, the Third Affiliated Hospital of Southern Medical University, Southern Medical University, Guangzhou, China. xiaogang2993@yeah.net.
Liping WangThe First Affiliated Hospital of Shenzhen University, Reproductive Medicine Centre, Shenzhen Second People's Hospital, Shenzhen, China. wlilyu@hotmail.com.
Yumei HeDepartment of Immunology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China. hym0909@smu.edu.cn.
Southern Medical University · CNThird Affiliated Hospital of Southern Medical University · CNShenzhen Second People's Hospital · CN

Funding

Guangdong Province Introduction of Innovative R&D Team (Introduction of Innovative R&D Team Program of Guangdong Province) 2019TQ05Y585Guangzhou Municipal Science and Technology Project 201904010073National Natural Science Foundation of China (National Science Foundation of China) 31700061Natural Science Foundation of Guangdong Province (Guangdong Natural Science Foundation) 2019A1515011435
6 · The paper itself

Abstract

The maternal immune system is vital in maintaining immunotolerance to the semiallogeneic fetus for a successful pregnancy. Although studies have shown that myeloid-derived suppressor cells (MDSCs) play an important role in maintaining feto-maternal tolerance, little is known about the role of MDSCs in pregnancies with intrauterine growth retardation (IUGR). Here, we reported that the activation of polymorphonuclear myeloid-derived suppressor cells (PMN-MDSCs) during pregnancy was closely associated with fetal growth. In humans, class E scavenger receptor 1 (SR-E1), a distinct marker for human PMN-MDSCs, was used to investigate PMN-MDSC function during pregnancy. Continuous activation of SR-E1

Indexed as

Myeloid-Derived Suppressor CellsAnimalsFemaleFetal DevelopmentImmune ToleranceMicePlacentaPregnancySignal TransductionClass E scavenger receptor 1Fetal developmentImmunotoleranceIntrauterine growth retardationPolymorphonuclear myeloid-derived suppressor cells

Identifiers

PMID34099889
PMCPMC8245399
OpenAlexW3171440763

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.